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Abstract
Background: Biological molecules are often asymmetric with respect to stereochemistry, and correct
stereochemistry is essential to their function. Molecular dynamics simulations of biomolecules have increasingly
become an integral part of biophysical research. However, stereochemical errors in biomolecular structures can
have a dramatic impact on the results of simulations.
Results: Here we illustrate the effects that chirality and peptide bond configuration flips may have on the
secondary structure of proteins throughout a simulation. We also analyze the most common sources of
stereochemical errors in biomolecular structures and present software tools to identify, correct, and prevent
stereochemical errors in molecular dynamics simulations of biomolecules.
Conclusions: Use of the tools presented here should become a standard step in the preparation of biomolecular
simulations and in the generation of predicted structural models for proteins and nucleic acids.
Background
Biomolecules often feature asymmetries in stereochemis-
try. Many biologically active molecules are chiral, i.e.,
they exist in two forms, called enantiomers, which are
non-superimposable mirror images of each other. Of
particular relevance to biological compounds is the car-
bon atom as a chiral center: a carbon atom is chiral if it
carries four nonequivalent substituents. Thus, all amino
acids save glycine have at least one chiral center at Ca
(see Figure 1A). Threonine and isoleucine have an addi-
tional chiral center at Cb. Interestingly, only one of the
two enantiomers is widely used in nature: according to
the D-/L-naming convention, most naturally occurring
amino acids are found in the L-configuration. Note,
however, that D-amino acids do occur in biology, e.g., in
cell walls of bacteria [1-3]. Nucleic acids also have chiral
centers. For example, in DNA the atoms C1’,C 3 ’,a n d
C4’ of the sugar moiety are chiral, while in RNA the
presence of an additional OH group renders also C2’ of
the ribose chiral (see Figure 1B). Although the origin of
the homochirality is not understood, the asymmetry due
to preferential use of one enantiomer in biological sys-
tems has wide consequences. In particular, recognition
processes of chiral molecules are impacted as can be
demonstrated, e.g., by the different smell of D- and L-
carvone or by the inhibition of proteases by D-amino
acids [4]. On the level of protein structure, the occur-
rence of D-amino acids in an L-amino-acid environment
is known to disrupt secondary structure [5,6]. The cru-
cial role of the correct enantiochemistry can be also
seen in the fact that organisms tightly control the use of
D-amino acids. Some of the aminoacyl-tRNA synthe-
tases, which implement the genetic code by loading a
tRNA with the corresponding amino acid have proof-
reading capabilities to exclude D-amino acids [7]. Addi-
tionally, organisms have evolved specific enzymes,
deacylases, which are able to recognize tRNAs acylated
with a D-amino acid and cleave the bond between the
amino acid and the tRNA, thus preventing a D-acylated
tRNA from entering into protein synthesis [8].
Another type of asymmetry is encountered in the con-
formation of the peptide bond connecting the carboxy
end of one amino acid to the amino end of the next one
in a peptide or protein. Due to the partial double-bond
character of the Cn-Nn+1 bond, the atoms Ca, n,C n,O n,
Ca, n+1,N n+1 and its hydrogen are in a plane (see, how-
ever, Ref [9]) and the rotation around the Cn-Nn+1 bond
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Depending on the value of the dihedral angle ω
described by Ca, n,C n,N n+1 and Ca, n+1, one can distin-
guish cis (ω ≈ 0°) and trans (ω ≈ 180°) isomers [12] (see
Figure 1C). For sterical reasons, the trans isomer is
energetically more stable and, thus, is the prevalent
form in proteins. Additionally, the rather high rotational
barrier makes the interconversion of the two isomers a
very slow process at room temperature. Nevertheless, cis
peptide bonds can be found in nature [13,14]. The vast
majority of cis bonds are observed before a proline resi-
due, Xaa-Pro, with Xaa being any amino acid. The for-
mation of these cis peptides is catalyzed by special
enzymes, prolyl-cis/trans isomerases [15,16]. Prolyl-cis/
trans isomerization is an important molecular switch
[17] and the occurrence of enzymes specialized for this
particular isomerization underpins its biological signifi-
cance. Non-prolyl cis peptide bonds can also be found
in proteins, but much less frequently than Xaa-Pro
[13,14] and only one protein, DnaK, is known to pro-
mote peptide isomerization of non-prolyl peptide bonds
[18]. In particular, DnaK was found to accelerate the
isomerization of Ala-Xaa bonds, Xaa being Ala, Gly,
Glu, Ile, Leu, Lys, Met, or Ser. Metal ions can also play
a role both in stabilizing the cis isomer and in promot-
ing isomerization [19-22].
Correct stereochemistry of a structural model is
important for its interpretation and critical if the model
is to be subject to a molecular dynamics simulation.
Force fields typically employed in biomolecular simula-
tions do not contain terms to enforce stereochemistry
and support either enantiomer or peptide isomer. Errors
in the input structure usually persist throughout the
simulation and, as will be shown below, can propagate
and lead to severe artifacts. Even in cases where stereo-
chemical errors do not lead to such large-scale pro-
blems, such errors must be avoided since they represent
deviations of the simulated system from the biological
reality that is to be modeled. There is a steady trend in
the field of biomolecular simulations toward the study
of large biomolecular assemblies and the usage of mod-
els based on structure prediction. Our recent experience
[23-25] shows that stereochemical errors often arise in
the preparation of large systems for simulation, particu-
larly when some components must be modeled prior to
simulation.
A variety of servers and programs are available for
structure validation, a vital stage in the preparation of
files for deposition in a coordinate database. One exam-
ple is the SAVES server [26], which provides an inter-
face to tools such as PROCHECK [27], WHAT_CHECK
[28], and other programs to detect irregularities in geo-
metry and structure such as chirality, bond angles, close
contacts, or rotamer states of amino acid side chains.
O t h e re x a m p l e sw i t hs i m i l a rf unctionality include the
MolProbity [29] server as well as the PDB validation ser-
vice [30].
All of the aforementioned tools for structure valida-
tion are primarily designed to validate experimentally
obtained models and not to ensure proper stereochemis-
try in simulations. Additionally, although irregularities
a r er e p o r t e d ,n o n eo ft h et o o l sw ea r ea w a r eo fa l l o w
the user to inspect and correct stereochemical errors
easily and immediately. We have thus written software
tools to help researchers easily detect, correct, and avoid
stereochemical errors in simulations.
In the following, we start by illustrating how errors in
chirality and peptide bond configuration can affect
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L D
A B
C
CB
CA
C
CA
CB
C
C1’
C2’ C3’
C4’
HA HA
CA, n+1 CA, n+1
CA, n
CA, n
Figure 1 Selected stereochemical parameters of amino acids and nucleosides. (A) Chirality configuration at Ca of an amino acid; (B) chiral
centers at the ribose moiety of guanosine monophosphate; (C) cis and trans isomers of a peptide group. Carbon atoms are shown in green,
nitrogen in blue, oxygen in red, and hydrogen in white. Chiral centers are surrounded by a transparent purple sphere.
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simulations. We then present software tools to identify,
visually inspect, and interactively correct stereochemical
errors in structural models of proteins and nucleic acids.
Next, we discuss the most common sources of stereo-
chemical errors in simulations, alongside a systematic
analysis of the entire Protein Data Bank [31]. Finally, we
provide a recommended workflow to avoid stereochemi-
cal errors in biomolecular simulations.
Results and Discussion
Consequences of stereochemical errors in biomolecular
simulations
In order to understand more directly the effects that
errors in chirality or peptide bond configuration have
on secondary structure, consider three simulations
involving a 15-amino-acid-long a-helix AAQAAAA-
QAAAAQAA solvated in water. In the first simulation,
the helix is stereochemically correct. For the second
simulation, a chirality error is introduced at Ca of Gln8
(Figure 2A). In the third case, the peptide bond between
Gln8 and Ala9 is present as a cis isomer (Figure 2B).
Figure 3 shows the conformations of the peptides after
32ns for each of the three scenarios, as well as the sec-
ondary structure content throughout each trajectory. By
the end of the simulation the stereochemically correct
helix is intact; in fact, the secondary structure is main-
tained during the entire simulation (Figure 3A). In con-
trast, a flip in chirality introduces a kink of almost 90°
into the helix (Figure 3B). Interestingly, the two pieces
separated by the kink remain helical. This conforma-
tional change can be understood considering that a D-
amino acid in an environment with the backbone dihe-
drals /ψ of an L-amino acid helix features unfavourable
steric interaction between the side chain and the peptide
oxygen atom. The relaxation leading to the very promi-
nent kink brings the side chain of Gln8 out of the
eclipsed conformation relative to the peptide oxygen
atom. In case of the cis p e p t i d eb o n d ,t h ei n i t i a ld i s t u r -
bance in the hydrogen bond network stabilizing the
helix leads to a rearrangement of the network and to a
complete loss of helicity downstream of Gln8 (Figure
3C). The configuration of a peptide bond is central to
the types of secondary structure the peptide chain can
assume: only the trans isomer accepts and donates
hydrogen bonds in opposite directions allowing for for-
mation of a-helices and b-sheets.
As demonstrated above, the impact of errors in chiral-
ity or peptide bond isomerization on secondary struc-
ture can be dramatic. Note, however, that the chosen
example represents the worst case scenario in terms of
severity of the structural disturbance - in a real protein,
tertiary interactions may provide stabilization of the
native structure and, thus, dampen the effect or extend
the time scale on which the structural disturbance
becomes apparent.
Tools to identify, inspect, and correct stereochemical
errors
Having demonstrated the impact of stereochemical
errors on structure, the question of how to ensure
stereochemical correctness in simulation naturally arises.
In general, biological systems can contain amino acids
or sugars of different chirality, as well as both peptide
isomers. Thus, an automatic procedure to “correct” the
structure is not appropriate unless one is absolutely cer-
tain that only one enantiomer and isomer occurs.
Therefore, we designed a semi-automatic four-step pro-
tocol to correct errors and to ensure stereochemical
integrity of a simulated system. For both chirality and
peptide bond conformation, the protocol was implemen-
ted into easy-to-use plugins for the molecular visualiza-
tion and analysis program VMD [32], referred to as
Chirality and Cispeptide plugins, respectively. The plu-
gins make use of the molecular dynamics simulation
package NAMD [33] in the correction step. Both soft-
ware packages are open source and freely available. The
current implementation provides both a graphical and
a command-line user interface. Use of each plugin
follows a similar 4-step process, namely: (1) identify
Correct Gln8
(view similar to 
chirality plugin)
B
Wrong Gln8
(view similar to 
chirality plugin)
Correct Gln8-Ala9
(view similar to 
cispeptide plugin)
Wrong Gln8-Ala9
(view similar to 
cispeptide plugin)
D-Gln8 trans Gln8-Ala9 cis Gln8-Ala9 L-Gln8 A
Figure 2 Stereochemical manipulations used for the illustrative simulations. Stereochemical manipulations used for the illustrative
simulations. (A) Different configurations at the chiral Ca at Gln8. (B) Different isomers at the Gln8-Ala9 peptide bond.
Schreiner et al. BMC Bioinformatics 2011, 12:190
http://www.biomedcentral.com/1471-2105/12/190
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anomaly and decide if it should be corrected; (3) move
selected atoms as to change the stereochemical config-
uration; and (4) locally optimize the structure. In the
following, we describe the four steps using the Cispep-
tide plugin as an example. Full documentation is avail-
able on the VMD website [34]. An additional step-by-
step practical guide can be found in a tutorial describing
both plugins [35].
In step (1), unusual stereochemical configurations (cis
peptide bonds in case of the Cispeptide plugin) are iden-
tified. A peptide bond is considered to be an irregularity
if the value of the dihedral angle ω’ formed by On,C n,
Nn+1 and Ca, n+1 is larger than 85°. The slightly differ-
ent, but equivalent, definition of the angle with respect
to ω ensures unique atom names used for the angle
measurement (exploited for computational efficiency)
and the threshold is chosen so as to avoid false positives
while maximizing the sensitivity when all the structures
of the PDB were tested (see “Sources of stereochemical
error below”). For chiral centers, the improper angle
made up of non-hydrogen atoms with the chiral atom in
the center is used to define non-standard configurations:
a negative value of the considered improper indicates an
unusual chirality. All identified irregularities are dis-
played in the corresponding panel (see “Identified cis
peptide bonds” in Figure 4A). In step (2), the irregulari-
ties are inspected and a decision is made whether to
keep or to modify each stereochemical configuration.
Clicking on each stereochemical anomaly generates a
corresponding molecular visualization (Figure 4B). As
mentioned before, there are tools [36] that may help
decide if the cis configuration is correct or if it should
be switched to trans.I ns t e p( 3 ) ,f o re a c hcis peptide
bond to be manipulated, the user selects an atom
(hydrogen or oxygen) to be moved (see Figure 4A). Ca
atoms are not allowed to move in order to minimize the
structural impact. The movements are reflections of the
positions of hydrogen or oxygen relative to the peptide
nitrogen or carbon, respectively (see Figure 4C). Which
of the two atoms should be moved highly depends on
the environment, and is thus not automated. By visual
inspection, the user can quite confidently determine
which atom (hydrogen or oxygen) should be moved in
order to optimize the hydrogen bonding network.
Finally, in step (4) a local structure optimization is car-
ried out using NAMD through the interactive molecular
dynamics [37,38] interface in VMD (Figure 4D). To
Stereochemically
correct
Chiral error 
at position 8
Cis peptide bond 
at position 8-9
32ns 32ns 32ns
ABC
5
10
15
1
Figure 3 Impact of stereochemical errors on the structure of an a-helix. Impact of stereochemical errors on the structure of an a-helix. The
figure shows the starting conformations, the conformations after 32 ns of equilibrium simulation, as well as the secondary structure content
throughout the simulation for (A) a stereochemically correct helix, (B) a helix with a D-Gln8, and (C) a helix with a cis peptide Gln8-Ala9. The axis
on the left shows residue numbers and the red dashed line indicates the position of the introduced stereochemical errors. The colors in the
bottom panels represent secondary structure content: helix (pink), turn (cyan) and coil (white).
Schreiner et al. BMC Bioinformatics 2011, 12:190
http://www.biomedcentral.com/1471-2105/12/190
Page 4 of 9enforce the target isomer, local restraints on the peptide
dihedral are employed. The local nature of the manipu-
lation and relaxation, which only involves residues
within a given cutoff, prevents widespread influence of
the procedure on the system. Finally, once the system is
stereochemically correct, restraints can be constructed
and used during further relaxation steps, prior to pro-
duction simulations, to prevent changes in
stereochemistry.
Sources of stereochemical errors
Most molecular dynamics simulations of single proteins
are relatively safe from stereochemical errors, given that
molecular structures are validated upon deposition into
the PDB. The irregularities detected in the validation
step are usually either corrected or reported in the
header of the PDB file. Using a structure from the PDB
for simulations, together with a careful examination of
the file header, usually means that the stereochemical
integrity of the simulation is secure (barring special
cases discussed below), because during an equilibrium
simulation the force field will preserve stereochemistry.
However, since force fields used for molecular dynamics
simulations support both types of chirality as well as
both peptide bond isomers, an existing error will persist
throughout the simulation.
To quantify stereochemical anomalies within the Pro-
tein Data Bank, all the structures contained in the PDB
were analyzed using the Chirality and Cispeptide VMD
plugins introduced above. As shown in Table 1 around
4,000 unusual configurations with respect to chirality
could be found in protein and nucleic acid structures, as
well as more than 100,000 cis peptide bonds. Analysis of
the complete dataset shows that one chirality error is
A B
C
D
Figure 4 The Cispeptideplugin. (A) The main window of the plugin showing the selection options in the top form, identified cis peptide
bonds in the center form, and options to move atoms and to relax the structure in the bottom form. (B) Molecular visualization highlighting the
selected bond generated by the plugin. (C) The configuration generated upon moving the oxygen atom along the C-O bond. (D) The control
window for interactive molecular dynamics used in the correction of unusual configurations.
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Page 5 of 9expected for every 10,000 residues, whereas for every
few hundred residues a cis peptide bond can be
expected. The likelihood of stereochemical anomalies
varies with the structure determination method, in parti-
cular when chirality is concerned. For example, for
structures derived from electron microscopy, one chiral-
ity error can be expected for every 500 residues (see
Table 1). The higher error rate seen in electron micro-
scopy-derived structuresa r el i k e l yd u et ot h em u c h
lower resolution on average, combined with use of a
wide range of modeling approaches, including manual
manipulation of structures.
In a subset of structures, chirality errors (153 struc-
tures) and cis peptide bonds (62 structures) were
reported in the PDB file, but were not detected by the
plugins. To understand the discrepancies, about half of
the structures in each subset was visually inspected. In
the case of cis peptides, the differences were due to
missing atoms in the deposited model, errors being pre-
sent in only one alternative conformation or model (see
Methods), pathologically distorted structures, and, most
frequently, incorrect entries in the PDB header. Simi-
larly, the reasons for the discrepancies in chirality were
that errors occurred in cofactors not checked by the
plugin, the anomalies were present in only one alterna-
tive conformation or model (see Methods), or the anno-
tations in the PDB header were incorrect.
The plugins also identified many structures with
stereochemical anomalies not reported in the PDB
header. According to the current PDB format standard,
each cis peptide bond should be reported in a separate
CISPEP record. It is then possible to compare each
identified cis peptide bond with the PDB header. There
were in total 2,518 cis peptide bonds identified by the
Cispeptide plugin but not reported in the PDB files.
Visual inspection of 20 such files did not reveal any
incorrect identification by the plugin. Chirality issues
should be reported in CAVEAT records of the PDB
header. Unfortunately, since CAVEAT records are free
format, rarely are chirality errors individually reported.
Furthermore, many PDB structures have chiral errors
inconsistently documented in REMARK 500 records
instead. Thus, a similar comparison on a per-error basis
cannot be performed for the Chirality plugin; instead,
we can only report that 348 PDB files contain chirality
anomalies according to the Chirality plugin, but lack the
corresponding annotation int h e i rP D Bh e a d e r s .U p o n
visual inspection of 20 files, the structures fell into two
categories: either there should be a D-amino acid (non-
ribosomal peptides) or the PDB header is simply missing
the required annotation.
Apart from errors already present in experimentally
determined structures, our experience shows that there
are three main sources of stereochemical errors in simu-
lations. The first source is found in modeling steps, par-
ticularly homology modeling: any regions of a structure
that were modeled de novo, especially at the junctions of
the known and modeled part of a protein, are prone to
peptide isomerization errors. The second common
source is found in the setup protocol for a simulation.
This includes the preparation of the system and its
initial relaxation. In particular, sterical clashes between
atoms can lead to errors in chirality and isomerization
state of peptide bonds. Again, such behavior is particu-
larly likely at the interface between known and modeled
portions of a structure, which may contain severe distor-
tions prior to equilibration. Although the barriers for
isomerization or a flip in chirality are large enough to
prevent these events in an equilibrium simulation at
physiological temperatures (e.g., 21 kcal/mol in
CHARMM22 [39]), forces arising during the initial
structure optimization, necessary to relax possible
c l a s h e s ,m a yb el a r g ee n o u gh to introduce errors into
the structure. This source of errors becomes increasingly
Table 1 Chirality errors and cis peptide bonds in the Protein Data Bank
Method
1 Chirality errors Cis peptide bonds
Total
2 Residues per
error
3
Structures
analyzed
4
Structures with
errors
Total
2 Residues per cis
bond
3
Structures
analyzed
4
Structures with
cis bonds
All 4047 9746 67942 648 (1%) 104455 368 65899 28576 (43%)
Electron microscopy 1273 529 201 40 (20%) 2316 262 192 93 (48%)
Solution NMR 280 2684 8444 105 (1%) 1289 565 7574 818 (11%)
X-ray diffraction 2494 15230 59147 503 (1%) 100776 368 57987 27646 (48%)
1 As given by EXPDTA record on each PDB file. Entries with more than one method were classified based on the first method listed. Only methods with at least
100 solved structures are shown in the table.
2 Total number of chirality errors or cis peptide bonds detected by the Chirality and Cispeptide VMD plugins, respectively.
3 Total number of residues divided by total number of chirality errors or cis peptide bonds. For chirality errors, all protein and nucleic acid residues are counted;
for cis peptide bonds, only protein residues are counted.
4 For chirality, only structures containing at least one protein or nucleic acid residue were considered. For cis peptide bonds, only structures containing at least
one peptide bond were kept in the analysis.
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moves towards multi-component assemblies, the struc-
tures of which are often modeled based on high-resolu-
tion models of their constituents and low-resolution
data of the whole complex. Finally, errors can also be
introduced during structure optimizations if additional
forces are applied on the system. Of particular interest
at this point is the molecular dynamics flexible fitting
(MDFF) method [40], which flexibly fits atomic-resolu-
tion structures into low-resolution density maps. In
some (rare) cases, it was observed that forces arising
from the MDFF method during initial structure optimi-
zation were large enough to cause stereochemical errors.
System setup protocols where the system is simulated at
very high temperatures (e.g., to obtain heat-denatured
structures) may also allow incorrect isomerization
events.
The Chirality and Cispeptide plugins can be
used to generate harmonic restraints designed to pre-
serve the current isomerization state of each chiral cen-
ter and peptide bond. The restraints can be used in
simulations with NAMD, effectively preventing stereo-
chemical errors from arising during simulation. These
restraints should be removed prior to production equili-
brium simulations, since they are not required and
would represent an unnecessary modification of the
force field employed.
Recommended workflow
In order to avoid stereochemical errors, the following
simple workflow is recommended for standard MD
simulations:
1. Build system for MD simulation (model missing
components, assemble structure, embed system in a
water box, and add counterions).
2. Energy-minimize structure.
3. Check stereochemistry with the Chirality and Cis-
peptide plugins, correcting errors if applicable.
Repeat until no further errors are detected. Make
sure that the detected irregularities are indeed errors
and not naturally occurring.
4. Proceed to production simulation.
For simulations in which large forces are expected (e.
g., flexible fitting with the MDFF method [40] or tem-
perature-induced denaturation), it is recommended that,
in addition to the workflow above, harmonic restraints
generated by the Chirality and Cispeptide plugins are
applied throughout the simulation.
Conclusions
The simulations presented here illustrate the drastic
effects that stereochemical errors can have in
biomolecular simulations. Experimentally determined
structures may contain stereochemical errors, and var-
ious modeling approaches can further increase the num-
ber of such errors. As the community moves toward
simulation of large, multi-component complexes and
uses to an increasing extent models based on structure
prediction, the issue of stereochemical correctness
becomes even more relevant. We thus developed tools
to identify, inspect, and correct stereochemical errors in
protein and nucleic acid structures. In particular, chiral-
ity and the isomerization state of a peptide bond are
examined. The main advantage of the offered tools is
the possibility to immediately inspect and correct the
detected errors. The tools are implemented as plugins
to the molecular visualization and analysis program
VMD. The recommended workflow presented above
effectively avoids artifacts in simulations due to stereo-
chemical errors. We hope that checks for stereochemical
correctness become a standard step of any biomolecular
simulation or generation of predicted structural models
for proteins and nucleic acids.
Availability and Requirements
￿ Project name: cispeptide, chirality; included into
VMD
￿ Project home page: http://www.ks.uiuc.edu/
Research/vmd
￿ Operating system(s): Platform independent
￿ Programming language: Tcl
￿ Other requirements: VMD 1.9 or higher, for mole-
cular dynamics part: NAMD 2.7 or higher
￿ License: UIUC Open Source License http://www.
ks.uiuc.edu/Research/vmd/plugins/pluginlicense.html
http://www.ks.uiuc.edu/Research/namd/license.html
Methods
Molecular dynamics simulations
Molecular dynamics simulations were conducted using
NAMD 2.7 [33]. The system consisted of the 15-amino-
acid-long a-helix AAQAAAAQAAAAQAA solvated in
TIP3P water. The N-a n dC-terminus were acetylated
and amidated, respectively. The system was set up in
VMD [32]. In particular, the helix was constructed using
the molefacture plugin, after which the full system was
built with the solvate and psfgen plugins.
All simulations were performed in the NpT ensemble
(T = 310 K, p = 1 atm). The stereochemically correct
system was equilibrated using a 2-step protocol. First,
water and side chains were equilibrated for 400 ps while
the backbone of the peptide was restrained, after which
all restraints were removed and the system was equili-
brated for an additional 3.6 ns. The resulting structure
was used to manually introduce a chirality flip at Gln8
and to isomerize the peptide bond between Gln8 and
Schreiner et al. BMC Bioinformatics 2011, 12:190
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Page 7 of 9Ala9 into the cis form (see Figure 2). Starting from the
three obtained systems, the simulations were continued
for 32 ns in each case. The equations of motion were
integrated using periodic boundary conditions and a 2-fs
time step, with bonded interactions calculated every 2
fs. Nonbonded, short-range interactions were calculated
every 4 fs using a distance cut-off of 10 Å with a switch-
ing function applied at 9 Å. Long-range electrostatic
interactions were updated every 6 fs using the Particle
Mesh Ewald (PME) method and the PME grid density
was never less than 1/Å
3. The simulations presented
here were performed with the CHARMM27 force field
[39,41] with the CMAP correction [42].
Analysis of the PDB
Each structure available in the PDB as of mid-Septem-
ber 2010 was analyzed using the Chirality and Cispep-
tide VMD plugins. In case of multiple models (typically
in structures solved by NMR), only the first model was
considered in the analysis. When multiple alternative
conformations of certain residues were present, as indi-
cated by the altLoc field in the PDB file, only the first
conformation was considered. For comparison and vali-
dation purposes, each PDB file header was parsed for
reported cis peptide bonds (CISPEP records) and unu-
sual chirality configurations (CAVEAT and REMARK
500 records).
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